OCS Liver PROTECT Continuation Post-Approval Study
- Conditions
- Liver Transplant
- Registration Number
- NCT05096741
- Lead Sponsor
- TransMedics
- Brief Summary
Post-approval observational study of subjects that were enrolled and transplanted in the OCS Liver PROTECT Trial.
- Detailed Description
Post-approval observational study of subjects that were enrolled and transplanted in the OCS Liver PROTECT Trial.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 300
- Subjects transplanted in the OCS Liver PROTECT Trial
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Liver Graft Survival 2 years Liver Graft Survival through 2 years (24 months) after transplantation.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (17)
University of California San Diego
🇺🇸La Jolla, California, United States
Scripps
🇺🇸San Diego, California, United States
University of California San Francisco
🇺🇸San Francisco, California, United States
Tampa General
🇺🇸Tampa, Florida, United States
Emory
🇺🇸Atlanta, Georgia, United States
Johns Hopkins
🇺🇸Baltimore, Maryland, United States
Massachusetts General Hospital
🇺🇸Boston, Massachusetts, United States
Henry Ford Hospital
🇺🇸Detroit, Michigan, United States
University of Minnesota
🇺🇸Minneapolis, Minnesota, United States
Ohio State University Medical Center
🇺🇸Columbus, Ohio, United States
Scroll for more (7 remaining)University of California San Diego🇺🇸La Jolla, California, United States